Dichlorvos, an Effective Broad-Spectrum Anthelmintic

A. Peña ChavarríaLouisiana State University International Center for Medical Research and Training (LSU-ICMRT), San José, Costa Rica and San Juan de Dios Hospital, New Orleans, Louisiana, Costa Rica

Search for other papers by A. Peña Chavarría in
Current site
Google Scholar
PubMed
Close
,
J. C. SwartzwelderLouisiana State University International Center for Medical Research and Training (LSU-ICMRT), San José, Costa Rica and San Juan de Dios Hospital, New Orleans, Louisiana, Costa Rica

Search for other papers by J. C. Swartzwelder in
Current site
Google Scholar
PubMed
Close
,
V. M. VillarejosLouisiana State University International Center for Medical Research and Training (LSU-ICMRT), San José, Costa Rica and San Juan de Dios Hospital, New Orleans, Louisiana, Costa Rica

Search for other papers by V. M. Villarejos in
Current site
Google Scholar
PubMed
Close
,
E. KotcherLouisiana State University International Center for Medical Research and Training (LSU-ICMRT), San José, Costa Rica and San Juan de Dios Hospital, New Orleans, Louisiana, Costa Rica

Search for other papers by E. Kotcher in
Current site
Google Scholar
PubMed
Close
, and
J. ArguedasLouisiana State University International Center for Medical Research and Training (LSU-ICMRT), San José, Costa Rica and San Juan de Dios Hospital, New Orleans, Louisiana, Costa Rica

Search for other papers by J. Arguedas in
Current site
Google Scholar
PubMed
Close
Restricted access

We wished to evaluate the safety and anthelmintic efficacy for man of dichlorvos (Dichlorman®), a new anthelmintic compound. Clinical, parasitologic, and pharmacologic studies were conducted on 108 hospitalized adult patients. The drug was administered in a granular-resin formulation that permits slow liberation in the intestinal tract. Formalinether (MGL) and Stoll egg-count techniques were employed for evaluation of therapy at different dosage levels. A wide range of laboratory studies was done, with particular emphasis on plasma and red-cell cholinesterase determinations. Despite the fact that the drug caused reduction in plasma cholinesterase levels, no clinical side-effects were observed in the carefully monitored patients, except for brief mild headache in a few. Cure rates of infections, with a single oral dose of 12 mg per kilogram of body weight, were 85.7% for hookworm, 87.8% for Trichuris trichiura, and 77.8% for Ascaris lumbricoides; egg-count reductions in the cases not completely cured were 97.3, 98.5, and 83.7 percent, respectively.

Save